ATE108799T1 - Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten. - Google Patents

Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.

Info

Publication number
ATE108799T1
ATE108799T1 AT89400334T AT89400334T ATE108799T1 AT E108799 T1 ATE108799 T1 AT E108799T1 AT 89400334 T AT89400334 T AT 89400334T AT 89400334 T AT89400334 T AT 89400334T AT E108799 T1 ATE108799 T1 AT E108799T1
Authority
AT
Austria
Prior art keywords
conjugates
derivatives containing
chain
detergent
vinca
Prior art date
Application number
AT89400334T
Other languages
English (en)
Inventor
Rao Ksp Siva Bhushana
Jean-Paul Dejonghe
Marie-Paule Collard
Andre Trouet
Original Assignee
Wallone Region
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallone Region filed Critical Wallone Region
Application granted granted Critical
Publication of ATE108799T1 publication Critical patent/ATE108799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
AT89400334T 1988-02-08 1989-02-07 Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten. ATE108799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8801439A FR2626882B1 (fr) 1988-02-08 1988-02-08 Conjugues de derives de vinca comportant une chaine detergente en position c-3

Publications (1)

Publication Number Publication Date
ATE108799T1 true ATE108799T1 (de) 1994-08-15

Family

ID=9363041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89400334T ATE108799T1 (de) 1988-02-08 1989-02-07 Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.

Country Status (8)

Country Link
US (1) US5024835A (de)
EP (1) EP0328446B1 (de)
JP (1) JP2930965B2 (de)
AT (1) ATE108799T1 (de)
CA (1) CA1336119C (de)
DE (1) DE68916820T2 (de)
ES (1) ES2057157T3 (de)
FR (1) FR2626882B1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4122210C2 (de) * 1991-07-04 1999-04-01 Deutsches Krebsforsch Konjugate aus tumoraktiver Verbindung und Serumalbumin sowie Verfahren zu deren Herstellung und ihre Verwendung
US5379254A (en) * 1992-10-20 1995-01-03 National Semiconductor Corporation Asymmetrical alternate metal virtual ground EPROM array
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides
DE69535665T2 (de) * 1994-08-19 2009-04-02 La Region Wallonne Konjugate enthaltend ein antitumorales mittel und deren verwendung
DE4433890C2 (de) * 1994-09-22 1999-02-18 Deutsches Krebsforsch Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein
EP0845987A4 (de) * 1995-08-08 2000-05-24 Fibrogen Inc C - proteinaseinhibitoren zur behandlung von störungen, die mit einer kollagenüberproduktion zusammenhängen
US5998362A (en) * 1996-09-12 1999-12-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6127333A (en) * 1997-07-10 2000-10-03 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6391305B1 (en) 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
EP1036093A1 (de) * 1997-12-02 2000-09-20 Merck & Co., Inc. Konjugate zur verwendung in der behandlung von prostatakrebs
ZA9810974B (en) * 1997-12-02 1999-06-03 Merck & Co Inc Conjugates useful in the treatment of prostate cancer
US20040081659A1 (en) * 1997-12-02 2004-04-29 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
AU5240999A (en) * 1998-07-31 2000-02-21 Goldsmith Seeds Inc. Trimeric and polymeric alkaloids
US6174858B1 (en) 1998-11-17 2001-01-16 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US7425541B2 (en) * 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
AU2001266853B2 (en) 2000-06-14 2005-02-17 Medarex, Inc. Prodrug compounds with an oligopeptide having an isoleucine residue
AU2001286391A1 (en) * 2000-07-05 2002-01-14 Crt Holdings, Inc. An electromagnetic radiation-initiated plasma reactor
US20030232760A1 (en) * 2001-09-21 2003-12-18 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US8946387B2 (en) * 2002-08-14 2015-02-03 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8530627B2 (en) * 2002-08-14 2013-09-10 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8968730B2 (en) * 2002-08-14 2015-03-03 Macrogenics Inc. FcγRIIB specific antibodies and methods of use thereof
US8044180B2 (en) * 2002-08-14 2011-10-25 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8187593B2 (en) * 2002-08-14 2012-05-29 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US20090017023A1 (en) * 2002-08-14 2009-01-15 Macrogenics, Inc. FcGammaRIIB Specific Antibodies and Methods of Use Thereof
US8193318B2 (en) * 2002-08-14 2012-06-05 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US7355008B2 (en) * 2003-01-09 2008-04-08 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
US7960512B2 (en) 2003-01-09 2011-06-14 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
SG148161A1 (en) * 2003-11-05 2008-12-31 Palingen Inc Enhanced b cell cytotoxicity of cdim binding antibody
CA2565874C (en) * 2004-05-10 2017-10-03 Macrogenics, Inc. Humanized fc.gamma.riib-specific antibodies and methods of use thereof
AU2005335714B2 (en) * 2004-11-10 2012-07-26 Macrogenics, Inc. Engineering Fc antibody regions to confer effector function
DK2573114T3 (en) 2005-08-10 2016-07-04 Macrogenics Inc The identification and production of antibodies with variant Fc regions, and methods of using same
JP2009529331A (ja) * 2006-03-10 2009-08-20 マクロジェニクス，インコーポレーテッド 変異型重鎖を有する抗体の同定および工学的改変ならびにその使用方法
CA2660592C (en) * 2006-05-26 2016-07-12 Macrogenics, Inc. Humanized fc.gamma.riib-specific antibodies and methods of use thereof
EP2029173B1 (de) * 2006-06-26 2016-07-20 MacroGenics, Inc. Fc-riib-spezifische antikörper und verfahren zu ihrer anwendung
EP2032159B1 (de) 2006-06-26 2015-01-07 MacroGenics, Inc. Kombination aus fcgammariib-antikörpern und cd20-spezifischen antikörpern sowie verwendungsverfahren dafür
US20080112961A1 (en) * 2006-10-09 2008-05-15 Macrogenics, Inc. Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
US8652466B2 (en) 2006-12-08 2014-02-18 Macrogenics, Inc. Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
CN106349390B (zh) 2008-04-02 2019-12-10 宏观基因有限公司 Bcr-复合体-特异性抗体和其使用方法
SG189730A1 (en) 2008-04-02 2013-05-31 Macrogenics Inc Her2/neu-specific antibodies and methods of using same
WO2010033279A2 (en) * 2008-06-04 2010-03-25 Macrogenics, Inc. Antibodies with altered binding to fcrn and methods of using same
MX2012004029A (es) 2009-10-07 2012-05-08 Macrogenics Inc Polipeptidos que contienen la region fc que exhiben funcion efectora mejorada debido a alteraciones del grado de fucosilacion, y metodos para su uso.
DK2542256T3 (da) 2010-03-04 2019-08-26 Macrogenics Inc Antistoffer reagerende med b7-h3, immunologisk aktive fragmenter deraf og anvendelser deraf
PH12012501751A1 (en) 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
CA2969689A1 (en) * 2014-12-03 2016-06-09 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
CN109069633A (zh) 2016-04-15 2018-12-21 宏观基因有限公司 新颖的b7-h3-结合分子、其抗体药物缀合物及其使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83822A1 (fr) * 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
FI820020A7 (fi) * 1981-01-12 1982-07-13 Lilly Industries Ltd Immunoglobuliinikonjugaatteja.
GR79899B (de) * 1983-03-30 1984-10-31 Lilly Industries Ltd
GR81790B (de) * 1983-04-29 1984-12-12 Omnichem Sa
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
EP0232693A3 (de) * 1985-12-16 1988-04-06 La Region Wallonne Konjugate des Vinblastins und seiner Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0233101A1 (de) * 1986-01-13 1987-08-19 Ire-Celltarg S.A. Vinblastin-Derivate und diese enthaltende Arzneimittel
FR2592883B1 (fr) * 1986-01-13 1988-09-16 Ire Celltarg Sa Derives de vinblastine et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
EP0328446B1 (de) 1994-07-20
EP0328446A1 (de) 1989-08-16
JPH02152992A (ja) 1990-06-12
US5024835A (en) 1991-06-18
CA1336119C (fr) 1995-06-27
ES2057157T3 (es) 1994-10-16
DE68916820T2 (de) 1995-03-09
DE68916820D1 (de) 1994-08-25
FR2626882A1 (fr) 1989-08-11
JP2930965B2 (ja) 1999-08-09
FR2626882B1 (fr) 1991-11-08

Similar Documents

Publication Publication Date Title
DE68916820D1 (de) Konjugate von in Position C-3 eine Detergens-Kette enthaltenden Vinca-Derivaten.
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
CY2175B1 (en) Pharmaceutical and other dosage forms
MY106598A (en) Compositions and methods for drug delivery and chromatography.
IT1144601B (it) Derivati della vinblastina procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali derivati
IL83079A (en) Nitrilotriacetic acid derivatives,metal chelate resins prepared therefrom and their use in chromatography
HUT40561A (en) Pharmaceutical compositions containing active agents being instable or insoluble in water, and process for producing these compounds
FI895693A7 (fi) Parantuneen liukoisuuden omaavia kantaja/lääkeainekoostumuksia ja menetelmä niiden valmistamiseksi
SE9002522L (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
ES2007409A6 (es) Un procedimiento para la preparacion de derivados de fenotiazina.
DK0909562T3 (da) Injektionspræparat indeholdende en lipid A analog og fremgangsmåde til fremstilling deraf
NZ236050A (en) Water soluble conjugate of a polymyxin and a carrier
HUT44267A (en) Process for preparing new organic platinum complexes
HUT41259A (en) Process for preparing pharmaceutical compositions in solide phase containing derivatives of dihydropyridine
AU678421B2 (en) Highly concentrated TCF pharmaceutical preparations
DK369287D0 (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
ZA907742B (en) Anticoagulant peptides
HUT53125A (en) Process for producing peptides with anticoagulant activity
FR2592883A1 (fr) Derives de vinblastine et composition pharmaceutique les contenant
DE69004151D1 (de) FR115224 enthaltende Zusammensetzung für eine parenterale Verabreichung.
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
ES2171183T3 (es) Analogos y conjugados de piperidina con procainamida y napa.
DE59107762D1 (de) Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren
DE58907569D1 (de) Isomere Trimethylbicyclo[4.3.0]nonan-Derivate.
ZA882762B (en) Novel derivative of d.25,process for its preparation,its use as an immunostimulant,and pharmaceutical compositions containing the derivative